Education
About Us
Working with TipRanks
Follow Us
Scorpius Holdings (SCPX)
OTHER OTC:SCPX
SCPX Stock Chart & Stats
$0.02
-$0.05(-12.22%)
At close: 4:00 PM EST
$0.02
-$0.05(-12.22%)
Day’s Range― - ―
52-Week Range$0.00 - $0.91
Previous CloseN/A
Volume714.61K
Average Volume (3M)5.55K
Market Cap
$85.60K
Enterprise Value$19.95T
Total Cash (Recent Filing)$520.52B
Total Debt (Recent Filing)$20.47T
Price to Earnings (P/E)―
Beta-7.35
Next Earnings
Mar 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding61,142,710
10 Day Avg. Volume3,056
30 Day Avg. Volume5,554
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)2.64
Price to Sales (P/S)2.66
P/FCF Ratio-0.62
Enterprise Value/Market Cap233.06M
Enterprise Value/Revenue87.68
Enterprise Value/Gross Profit1.44K
Enterprise Value/Ebitda-3.45
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Scorpius Holdings News
SCPX FAQ
What was Scorpius Holdings’s price range in the past 12 months?
Scorpius Holdings lowest stock price was $0.00 and its highest was $0.91 in the past 12 months.
What is Scorpius Holdings’s market cap?
Scorpius Holdings’s market cap is $85.60K.
When is Scorpius Holdings’s upcoming earnings report date?
Scorpius Holdings’s upcoming earnings report date is Mar 27, 2026 which is in 69 days.
How were Scorpius Holdings’s earnings last quarter?
Currently, no data Available
Is Scorpius Holdings overvalued?
According to Wall Street analysts Scorpius Holdings’s price is currently Overvalued.
Does Scorpius Holdings pay dividends?
Scorpius Holdings does not currently pay dividends.
What is Scorpius Holdings’s EPS estimate?
Scorpius Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Scorpius Holdings have?
Scorpius Holdings has 61,142,710 shares outstanding.
What happened to Scorpius Holdings’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Scorpius Holdings?
Currently, no hedge funds are holding shares in SCPX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Scorpius Holdings
Scorpius Holdings Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company provides analytical testing, downstream process development, formulation optimization and development, and clinical biomanufacturing services to pharmaceutical and biotech companies. It is also involved in the provision of pre-clinical and product development; chemistry, manufacturing, and control analytical support; and bioassays. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.
Technical Analysis
Scinai Immunotherapeutics
―
Aditxt
―
CERo Therapeutics Holdings
―
Psyence Biomedical
―
Conduit Pharmaceuticals
―
Ownership Overview
―
Insiders
<0.01% Mutual Funds
0.02% Other Institutional Investors
99.97% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---